Jiangsu Hengrui Pharmaceuticals (600276.SH) announced on July 1st that as of June 30, 2024, the company had repurchased a total of 2,514,504 shares through centralized bidding trading, accounting for 0.04% of the total share capital of the company. The highest transaction price was 40.77 yuan/share, the lowest was 39.00 yuan/share, and the total amount paid was 100,151,305.00 yuan (excluding transaction fees).
恒瑞医药(600276.SH)：累计回购0.04%股份
Jiangsu Hengrui Pharmaceuticals (600276.SH) has repurchased 0.04% of its shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.